Antibodies used for the screening approach. Detailed description of used antibodies. (DOCX 46 kb
Table S1. List of antibodies used in immunohistochemistry and in flow cytometry. (PDF 37 kb
Table S1. Immunomodulatory agents. Table S2. Non-immunomodulatory agents. (PDF 317 kb
Table S1. List of antibodies used in Western Blot and immunohistochemistry. (DOCX 14 kb
Supplemental experimental procedures. Detailed description of materials and methods. (DOCX 62 kb
Treatment history of breast cancer patients. Detailed description of treatment history of breast can...
Results of microarray analysis. Results of gene and miRNA expression profiling, Gene Ontology analys...
Tumor-initiating capacity of the SSEA4-positive and SSEA4-negative subpopulation. (a) One hundred th...
Table with overview of primary antibodies. Gives information about species reactivity, suppliers and...
List of antibodies and sources for use in immunofluorescent staining, co-immunoprecipitation, wester...
Expression of SSEA4 in RCC and healthy kidney tissue. Primary RCC and healthy kidney tissues from th...
Correlation among CD24-, CD44-, and SSEA4-expressing subpopulations. To address the correlation betw...
Representative gating strategy for flow cytometry–based marker analysis of dissociated xenograft tum...
List of antibodies used for the identification, characterization and isolation of bone marrow mesenc...
Details of primary antibodies used in the study. Details of primary antibodies used in the study inc...
Supplemental Information. Table S1. The source of primary antibodies used in this study. Table S2. T...
Table S1. List of antibodies used in immunohistochemistry and in flow cytometry. (PDF 37 kb
Table S1. Immunomodulatory agents. Table S2. Non-immunomodulatory agents. (PDF 317 kb
Table S1. List of antibodies used in Western Blot and immunohistochemistry. (DOCX 14 kb
Supplemental experimental procedures. Detailed description of materials and methods. (DOCX 62 kb
Treatment history of breast cancer patients. Detailed description of treatment history of breast can...
Results of microarray analysis. Results of gene and miRNA expression profiling, Gene Ontology analys...
Tumor-initiating capacity of the SSEA4-positive and SSEA4-negative subpopulation. (a) One hundred th...
Table with overview of primary antibodies. Gives information about species reactivity, suppliers and...
List of antibodies and sources for use in immunofluorescent staining, co-immunoprecipitation, wester...
Expression of SSEA4 in RCC and healthy kidney tissue. Primary RCC and healthy kidney tissues from th...
Correlation among CD24-, CD44-, and SSEA4-expressing subpopulations. To address the correlation betw...
Representative gating strategy for flow cytometry–based marker analysis of dissociated xenograft tum...
List of antibodies used for the identification, characterization and isolation of bone marrow mesenc...
Details of primary antibodies used in the study. Details of primary antibodies used in the study inc...
Supplemental Information. Table S1. The source of primary antibodies used in this study. Table S2. T...
Table S1. List of antibodies used in immunohistochemistry and in flow cytometry. (PDF 37 kb
Table S1. Immunomodulatory agents. Table S2. Non-immunomodulatory agents. (PDF 317 kb
Table S1. List of antibodies used in Western Blot and immunohistochemistry. (DOCX 14 kb